Compound 239
Identifiers
- Canonical SMILES:
COc1ccccc1Sc1ccc(cc1C(F)(F)F)-c1ccnc(c1)N1CCN(CC1)C=O
- IUPAC name:
4-[4-[4-(2-methoxyphenyl)sulfanyl-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazine-1-carbaldehyde
- InChi:
InChI=1S/C24H22F3N3O2S/c1-32-20-4-2-3-5-22(20)33-21-7-6-17(14-19(21)24(25,26)27)18-8-9-28-23(15-18)30-12-10-29(16-31)11-13-30/h2-9,14-16H,10-13H2,1H3
- InChiKey:
SUZAUKCYSQZDMS-UHFFFAOYSA-N
External links
21906755 |
CHEMBL360677 |
10657259 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 6.73 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 473.14 g/mol | |||
HBA | 5 | |||
HBD | 0 | |||
HBA + HBD | 5 | |||
AlogP | 5.04 | |||
TPSA | 45.67 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7400 | 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine | DB02177 | |
0.5337 | Netupitant | DB09048 | |
0.5210 | 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol | DB07969 | |
0.4975 | Bitopertin | DB12426 | |
0.4897 | Fosnetupitant | DB14019 | |
0.4755 | Mepyramine | DB06691 | |
0.4469 | Atevirdine | DB12264 | |
0.4386 | 4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine | DB03916 | |
0.4286 | Vortioxetine | DB09068 | |
0.4235 | Blonanserin | DB09223 | |
0.4192 | ABT-384 | DB12501 | |
0.4143 | Tripelennamine | DB00792 | |
0.4124 | Lecozotan | DB12540 | |
0.4098 | ORM-13070 C-11 | DB15324 | |
0.4096 | TT-301 | DB12899 |